Cardiovascular Systems

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.

3 past transactions

CarePICS

Corporate Round in 2021
CarePICS is a software application development company. They offer services for clinical outcomes, remove barriers to care, and make services. They provide services for the health care services industry.

Leviticus Cardio

Venture Round in 2015
Leviticus Cardio has developed wireless power transfer system capable of providing the day-to-day power needs of available VAD implants Most critical Heart Failure patients (30,000 to 60,000 in US) are candidates for heart transplantation or alternatively to Ventricular Assist Device (VAD), an implanted mechanical circulatory pump. VAD is connected to an external power pack by a drive line. Infection related to the drive line represents the single most important challenge to extended VAD use. Leviticus’s wireless system is robust, simple to implant, and efficient.

Replidyne

Acquisition in 2008
Replidyne is a specialty pharmaceutical company focused on developing and commercializing innovative anti-infective products. The company is building its development pipeline based on both its proprietary DNA replication technology and in-licensing efforts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.